Aberdeen Takes Charge of Vital Endometriosis Trials

The motion

That the Parliament congratulates the University of Aberdeen on securing £2.4 million from the National Institute for Health and Care Research to lead a major UK-wide trial of a new pain management programme for endometriosis, in partnership with NHS Grampian; recognises that endometriosis affects around one in 10 women, causing debilitating pelvic pain, chronic fatigue and disruption to education, work and relationships; acknowledges that, despite being one of the most common causes of chronic pain, endometriosis remains under-researched and, despite affecting millions of women, remains without a cure; notes that existing treatments, including surgery and medication, do not always provide lasting relief; welcomes the development of a 12-week endometriosis-specific pain management programme, combining psychological support, specialist physiotherapy and medication optimisation for women whose pain has not improved through existing treatment; notes that the trial will compare the new programme alongside standard care with standard care alone among premenopausal women, assessing both clinical outcomes and cost-effectiveness; believes that, if effective, the programme could provide a vital new treatment plan and help to shape future guidelines as well as NHS resource allocation, and welcomes the significant investment in tackling the impact of endometriosis, while stressing the need for continued funding in order to find a cure.

No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.

SNP 11 Con 1 Lab 1 Reform 1

Party shown is each supporter’s party when the motion was published.

No contribution in the Official Report cites S7M-01416 by reference.